Celebrating 25+ years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Prostate Cancer Foundation

CharityWatch report issued
October 2018

Top-Rated Charity
A-
CharityWatch Grade
Our independent grade based
on a number of factors.
 
79%
Program Percentage
Amount spent on programs
relative to overhead.
 
$13
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Prostate Cancer Foundation
1250 Fourth St.
Suite 360
Santa Monica, CA 90401-1353

Other Names

None

Tax Status

501(c)3

Website

www.pcf.org

Stated Mission

Committed to ending death and suffering from prostate cancer; accelerates the world's most promising prostate cancer research with the goal of developing new precision medicines and cures for prostate cancer.

View similar charities
Charity  
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Care  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation  
Children's Cancer Research Fund  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation  
Good Charity  
Leukemia & Lymphoma Society  
LiveStrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 12/31/2017

Program Percentage: 79%

The percentage of Prostate Cancer Foundation's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$45,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $13

How many dollars Prostate Cancer Foundation spends on fundraising to raise each $100 of contributions.

$44,000,000

Calculated Total Contributions

(rounded)

Joint Costs

Prostate Cancer Foundation's rating was adjusted for Joint Costs. If you are a donor who considers direct mail, telemarketing, and other Joint Cost solicitations to be true charitable programs, the below efficiency ratios, which were not adjusted for joint costs, may better reflect your goals.

Program % Cost to Raise $100
82% $11
Accounting rules allow charities to report some telemarketing, direct mail, and other solicitation costs as Program expenses. CharityWatch believes that most donors do not consider a charity's solicitation activities to be the Programs they are intending to support with their donations. We therefore adjust such expenses out of a charity's reported Program expense and add it to Fundraising expense prior to calculating its rating.

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
Prostate Cancer Foundation IRS Form 990 95-4418411
Prostate Cancer Foundation Consolidated Audited Financial Statements Multiple
Entity: Prostate Cancer Foundation
Document Type: IRS Form 990
Tax ID: 95-4418411
Entity: Prostate Cancer Foundation
Document Type: Consolidated Audited Financial Statements
Tax ID: Multiple

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
Prostate Cancer Foundation
meets governance benchmarks.
 
Prostate Cancer Foundation
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy No Sharing  

  Name Title Compensation
1 Jonathan W. Simons, M.D. President/CEO $1,288,873
  Note: Includes $620,000 bonus & incentive compensation.
2 Howard Soule Executive VP, Chief Science Officer $445,025
3 Tom Andrus Executive VP, Digital $389,070
1
Name: Jonathan W. Simons, M.D.
Title: President/CEO
Compensation: $1,288,873
Note: Includes $620,000 bonus & incentive compensation.
2
Name: Howard Soule
Title: Executive VP, Chief Science Officer
Compensation: $445,025
3
Name: Tom Andrus
Title: Executive VP, Digital
Compensation: $389,070

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.
CharityWatch's rating of Prostate Cancer Foundation (PCF) also includes the financial activities of the Coalition to Cure Prostate Cancer, which is consolidated in the PCF audited financial statements for the fiscal year ended December 31, 2017.

According to the PCF 2017 consolidated audit (Note 1, Nature of Organization):

"The Coalition to Cure Prostate Cancer (the Coalition) was incorporated under the Canada Corporations Act during April 2011. The Coalition was granted charitable registration effective June 15, 2011. The Coalition's mission is to pursue research and clinical studies related to prostate and related cancers and to disseminate research reports and other educational materials related to such cancers.

"The Coalition is an affiliate of the Prostate Cancer Foundation. Pursuant to terms of a service agreement, the Prostate Cancer Foundation has agreed to provide certain pro bono services to the Coalition, including communications and fundraising support, program service and financial administration, and facilities. In addition, the Prostate Cancer Foundation has extended a guaranty to the Coalition for up to a maximum of $100,000 to ensure that the Coalition will be able at all times to fund research awards approved by the Coalition's Board of Directors."

All inter-organization balances and transaction between PCF and the Coalition are eliminated in the audit consolidation.
According to the Prostate Cancer Foundation (PCF) consolidated audit of December 31, 2017 (Note 6, Related Party Transactions):

"Since the Foundation's inception in 1993 through December 31, 2017, it has received more than $64,000,000 in contributions from the Milken Family, the Milken Family Foundation and affiliated organizations."


According to the PCF 2017 tax filing, Michael Milken is listed as "Founder & Chairman" of PCF (IRS Form 990, Part VII, Section A).
According to the Prostate Cancer Foundation (PCF) 2017 tax filing, PCF reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III):

Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7):

"The Committee awarded discretionary bonuses to the officers and employees based on exceptional individual performance."


PCF reports "Bonus & incentive compensation" payments to nine individuals in 2017 (IRS Form 990, Schedule J, Part II). Three individuals each received "Bonus & incentive compensation" in the amount of $5,000, and one individual in the amount of $4,000. In addition, PCF reports "Bonus & incentive compensation" payments in the following amounts to the five individuals listed below:

-- Jonathan W. Simons, M.D., CEO & President: $620,000, with reported total compensation of $1,288,873;
-- Tom Andrus, EVP, Digital: $48,000, with reported total compensation of $389,070;
-- John Weston, EVP, Chief Operating Officer: $30,000, with reported total compensation of $364,836;
-- Helen Hsieh, SVP, Finance and Administration: $15,000, with reported total compensation of $293,209; and
-- Howard Soule, Ph.D., EVP, Chief Science Officer: $10,000, with reported total compensation of $445,025.

Related Articles

No related articles found